Reaping the benefits of genomic and proteomic research : intellectual property rights, innovation, and public health /

Mostrar otras versiones (1)

The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP restrict...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: National Research Council (U.S.). Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation
Otros Autores: Merrill, Stephen A., Mazza, Anne-Marie
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, ©2006.
Temas:
Genomics > United States > Patents.
Proteomics > United States > Patents.
Intellectual property > United States.
Genomics.
Proteomics.
Intellectual property.
Public health.
Genomics
Proteomics
Intellectual Property
Patents
Public Health
Génomique > États-Unis > Brevets d'invention.
Protéomique > États-Unis > Brevets d'invention.
Propriété intellectuelle > États-Unis.
Génomique.
Protéomique.
Propriété intellectuelle.
Santé publique.
intellectual property.
public health.
SCIENCE > Life Sciences > Genetics & Genomics.
Public health
Intellectual property
United States
Fulltext.
Internet Resources.
Patents.
patents.
Brevets d'invention.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Genomics, proteomics, and the changing research environment
  • The U.S. patent system, biotechnology, and the courts
  • Trends in the patenting and licensing of genomic and protein inventions and their impact on biomedical research
  • Conclusions and recommendations.

Ejemplares similares